The popularity of Sildenafil initially sparked a boom for major pharmaceutical companies, but recent shifts present a murky picture for investors. Lower-cost competitors are reducing profits, and persistent patent https://roxannarlv842464.ziblogs.com/41485167/sildenafil-and-the-pharmaceutical-industry-a-precarious-investment